Brief: Rosetta Genomics gets notice of rescission of conditional approval from New York State Department of Health for 4 of co's Allele-specific PCR-based assays
Aug 22 (Reuters) - Rosetta Genomics Ltd ROSG.O :
* Got notice of rescission of conditional approval from new
york state department of health for 4 of co's Allele-specific
PCR-based assays
* "Confident" it will be able to address concerns raised by
Nysdoh, plans to resubmit for nysdoh approval as soon as
possible-sec filing
* In the interim, the company will not process samples for
co's Allele-specific PCR-based assays from patients in New York
Source text (http://bit.ly/2bcho1x)
Further company coverage: ROSG.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics